 ST. LOUIS, Nov. 09, 2020 GLOBE NEWSWIRE -- Stereotaxis NYSE: STXS, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the third quarter ended September 30, 2020. 